Is Acura Pharmaceuticals, Inc. (ACUR) a Buy, Sell, or Hold?
OTC : ACUR
Acura Pharmaceuticals, Inc.
$0.0003 USD
$0.0 (200.0%)
- Volume
- 400
- Average Volume
- 327
- Market Capitalization
- $19.8K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.72
Company Overview
OTC
Robert Jones
Drug Manufacturers - Specialty & Generic
Healthcare
ACUR
9
US
USD
Liquidity Metrics
1.12
0.72
0.72
0.13
0.00
Sales & Valuation
$1.56M
0.01
0.07
-0.03
-0.02
Profitability
-$0.0155
-$879K
-56.24%
-56.24%
30.77%
-102.21%
P/E Metrics
-0.02
0.00
0.00
Analyst Price Target & Rating
0/5
3 Analysts
%
Financial Health Scores
-636.00
2/9
-$143K
$860K
$682K
-$679K
Key Metrics (TTM)
$141.6K
0.09
-0.24
0.72
30.77%
-295.38%
-20000.00%
-11242.42%
-742 days
Company Executives
| Name | Title |
|---|---|
| Robert Jones | Chief Executive Officer, President & Director |
| Robert A. Seiser | Chief Financial Officer, Senior Vice President, Treasurer & Corporate Controller |
Poll Results
No votes yet today — be the first to share your view!
About Acura Pharmaceuticals, Inc. (OTC:ACUR) Stock
Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic moderate-to-severe pain. The company also offers the Nexafed line, consisting of pseudoephedrine and acetaminophen tablets, widely utilized as nasal decongestants in a range of over-the-counter and prescription formulations for cold, sinus, and allergy relief. Beyond its current offerings, Acura is actively advancing six additional opioid products through various stages of formulation development. To support its global reach, Acura Pharmaceuticals mai ... ntains strategic collaboration and licensing agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide production and commercialization of its Oxaydo products. Furthermore, it has established a development and commercialization partnership with Abuse Deterrent Pharma, LLC to create LTX-03, an immediate-release tablet leveraging the proprietary LIMITx technology. Established in 1935, the company's operations are headquartered in Palatine, Illinois.
Frequently Asked Questions
-
What is the current Acura Pharmaceuticals, Inc. (ACUR) stock price?
-
Acura Pharmaceuticals, Inc.(OTC:ACUR) stock price is $0.0003 in the last trading session. During the trading session, ACUR stock reached the peak price of $0.01 while $0.0001 was the lowest point it dropped to. The percentage change in ACUR stock occurred in the recent session was 200.0% while the dollar amount for the price change in ACUR stock was $0.0.
-
ACUR's industry and sector of operation?
-
The OTC listed ACUR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of ACUR?
-
Robert Jones | Chief Executive Officer, President & Director
Robert A. Seiser | Chief Financial Officer, Senior Vice President, Treasurer & Corporate Controller
|
|
| -
How many employees does ACUR have?
-
Number of ACUR employees currently stands at 9. ACUR operates from 616 N. North Court, Palatine, IL 60067, US.
-
Link for ACUR official website?
-
Official Website of ACUR is: https://www.acurapharm.com
-
How do I contact ACUR?
-
ACUR could be contacted at phone #847 705 7709 and can also be accessed through its website. ACUR operates from 616 N. North Court, Palatine, IL 60067, US.
-
How many shares of ACUR are traded daily?
-
The average number of ACUR shares traded daily for last 3 months was 327.
-
What is the market cap of ACUR currently?
-
The market value of ACUR currently stands at $19.8K with its latest stock price at $0.0003